Meeting
2020 ASCO Virtual Scientific Program
PD-1 protein and gene expression in early breast cancer: Prognostic implications.
Authors
Ioannis Zerdes
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Ioannis Zerdes , Alexios Matikas , John Lövrot , Emmanouil G. Sifakis , François Richard , Christos Sotiriou , George Z. Rassidakis , Jonas C. S. Bergh , Antonios Valachis , Theodoros Foukakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 38: 2020 (suppl; abstr 545)
DOI
10.1200/JCO.2020.38.15_suppl.545
Abstract #
545
Poster Bd #
37
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC).
First Author: Jhe-Cyuan Guo
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of liver metastases, tumor microenvironment, and treatment outcomes in patients with urothelial bladder cancer treated with tislelizumab.
First Author: Linlin Xu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Association of punctate TAK1 expression with mortality in patients with microsatellite-stable colorectal cancer.
First Author: Norman James Galbraith
Poster
2022 ASCO Annual Meeting
The ImPrint immune signature to identify patients with high-risk early breast cancer who may benefit from PD1 checkpoint inhibition in I-SPY2.
First Author: Lorenza Mittempergher